News
NY Attorney General Letitia James secures $720 million from 8 drug companies for their role in the opioid crisis.
Merck is expanding its pipeline and portfolio of cardio-pulmonary disease treatments by acquiring Verona Pharma plc.
The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.
2d
InvestorsHub on MSNMerck to Acquire Verona Pharma in $10 Billion Deal to Expand Respiratory Drug PortfolioMerck (NYSE:MRK) announced Wednesday it has struck a definitive agreement to acquire Verona Pharma PLC ADR (NASDAQ:VRNA) in a transaction valued at approximately $10 billion, or $107 per American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results